Navigation Links
Vermillion Announces First Quarter 2008 Financial Results and Business Progress

d findings from an OSU clinical study that indicated that a

SELDI-TOF-based TTP diagnostic test, which already has been

commercially launched as a laboratory developed test by the

institution, also could be used to help estimate the risk of TTP

relapses during clinical remission. The data -- published in the

online edition of the British Journal of Haematology -- indicate

that use of the test may provide a novel screening strategy to

identify patients who may benefit from prophylactic treatment to

help prevent relapse of this serious blood disorder.

-- Corporate Developments

* Appointed John F. Hamilton, former vice president and chief

financial officer of Depomed, Inc., to the Vermillion Board of

Directors and to serve as chairman of the Audit Committee of the


* Received issuance of U.S. Patent No. 7,341,838 for the discovery of

novel forms of brain natriuretic peptide (BNP), which could

potentially improve upon the current standard of care in diagnosing

and treating cardiovascular disease. The discovery could ultimately

lead to the development of an improved, next-generation assay that

might provide physicians with additional, valuable information to

stratify patients at risk for cardiovascular disease.

* Renewed a long-standing collaboration with Johns Hopkins University

on the development of novel biomarkers that can be applied toward

disease detection, classification and monitoring of prevalent

cancers, including ovarian, breast and prostate. Vermillion will

have access to exclusive commercial rights to the discoveries made

through the partnership.

* Vermillion's stockholders and board of directors approved a 1 for


SOURCE Vermillion, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Vermillion (Formerly Ciphergen) Announces $20.5 Million Private Placement of Common Stock
2. Vermillion and Collaborators Discover Protein Biomarker Associated with Peripheral Artery Disease
3. Vermillion, Inc. Announces Receipt Of Notice Of Compliance From Nasdaq
4. Vermillion to Webcast Presentation at the Acumen BioFin 9th Annual Healthcare Conference, November 5-7, New York
5. Vermillion and Johns Hopkins Sign Collaborative Research and License Agreements to Develop Molecular Diagnostic Tests
6. Vermillion Receives NASDAQ Notice of Non-Compliance
7. Vermillion and Stanford University Sign Exclusive License Agreement for Novel Biomarker Panel to Assess Peripheral Artery Disease Risk
8. Vermillion Announces Effectiveness of Reverse Stock Split
9. Vermillion Summarizes Recent Accomplishments and 2007 Financial Results; Outlines 2008 Business Milestones
10. Vermillion Meets Minimum Bid Price and Receives NASDAQ Staff Determination Letter for Minimum Market Capitalization
11. Vermillion Biomarker Panel Potential Aid in the Diagnosis of Peripheral Artery Disease
Post Your Comments:
(Date:9/23/2014)... oxide ceramics have potential uses as ferroelectrics, fast ... nuclear waste, generating a great deal of scientific ... these blended materials. , "The interfaces separating the ... radiation properties of the material as a whole," ... researcher on the project. "It is in the ...
(Date:9/23/2014)... 2014 Erlab , the expert ... 1968 and Burdinola, supplier of laboratory furniture solutions, announce ... fume hood. , By integrating Erlab’s ... will now offer an innovative solution utilizing the patented ... chemicals, best-in-class detection technology, and communication for security and ...
(Date:9/23/2014)... CA (PRWEB) September 23, 2014 For the ... Inc. 500|5000 list of the fastest-growing companies. , ... been acknowledged yet again by Inc. Magazine,” ExakTime CEO Tony ... 5000 list by posting a three-year growth rate of 61 ... in that time by more than 40 percent. , Pappas ...
(Date:9/23/2014)... Sept. 23, 2014  Age Defying Dermatology ® , ... has become one of the first clinics in the ... aesthetic laser for tattoo removal. The treatment safely and ... "For years, tattoo removal has been a lengthy, painful, ... "This is an opportunity to erase tattoo pigment more ...
Breaking Biology Technology:Los Alamos researchers uncover properties in nanocomposite oxide ceramics for reactor fuel 2Erlab Partners with Burdinola to Deliver an Innovative Filtered Fume Hood 2ExakTime Makes Inc. 5000 List for the Fifth Time 2Age Defy Now Offers World's Most Advanced Technology for Tattoo Removal 2
... screening initiative launches in Atlanta and continues for 90 days;, ... in 13 cities ... across the country, ... specialty biopharmaceutical company, today,announced the launch of a 13-city mobile screening ...
... to Impact Lung Cancer Care, ST. LOUIS, ... start-up company, has secured $4.75M in venture capital ... delivery system for minimally,invasive biopsy and ablation of ... was joined by Advantage Capital Partners and existing ...
... EuroPCR08 will highlight choice of different modalities ... available on single integrated imaging platform., SAN DIEGO, ... VOLC ), a leading manufacturer and developer of,intravascular ultrasound ... designed to enhance the diagnosis and,treatment of coronary and ...
Cached Biology Technology:Shire Launches Nationwide Adult ADHD Mobile Awareness Tour 2Shire Launches Nationwide Adult ADHD Mobile Awareness Tour 3Shire Launches Nationwide Adult ADHD Mobile Awareness Tour 4Shire Launches Nationwide Adult ADHD Mobile Awareness Tour 5Veran Medical Technologies Secures $4.75M in First Institutional Funding 2Volcano Announces Placement of 1,000th s5 and s5i IVUS Imaging System 2Volcano Announces Placement of 1,000th s5 and s5i IVUS Imaging System 3Volcano Announces Placement of 1,000th s5 and s5i IVUS Imaging System 4
(Date:9/23/2014)... has domesticated animals, selecting the best traits possible ... an intriguing animal to examine adaptation to climate ... selected breeding and a wealth of livestock genome-wide ... study that combined molecular and environmental data, professor ... genes under environmental selection from domesticated sheep breeds. ...
(Date:9/23/2014)... at the University of Wisconsin-Madison and the Morgridge Institute ... to screen for neural toxins, helping flag chemicals that ... Health (NIH) announced today that the UW-Madison and Morgridge ... the promising work as part of the Tissue Chip ... $7 million over the three-year project. , The ...
(Date:9/23/2014)... new tissues during the healing process, cells must ... years, scientists believed this communication happened primarily through ... and the University of Pittsburgh have found that ... if not more crucial. The findings, published in ... the National Academy of Sciences , could lead ...
Breaking Biology News(10 mins):Being sheepish about climate adaptation 2UW-Madison team developing 'tissue chip' to screen neurological toxins 2UW-Madison team developing 'tissue chip' to screen neurological toxins 3The mechanics of tissue growth 2
... anything they want and never gain a pound, while others ... You may be seeing things correctly after all. According ... Genetics ( ), this may have a biological ... with diet, rather than diet alone, are the main cause ...
... (CLOTS)an intensive five-day course offered by the Society ... interventional radiologists, neurointerventionalists, vascular neurologists and fellows-in-training with ... discuss all aspects of acute stroke management. ... in the United States, with about 600,000 new ...
... Just as cooking helps people digest food, pretreating polycarbonate ... of its bisphenol A (BPA) content may be ... eco-friendly way, scientists have found. Their new study is ... Mukesh Doble and Trishul Artham note that manufacturers produce ...
Cached Biology News:Why fad diets work well for some, but not others 2Explore stroke care with Society of Interventional Radiology's CLOTS 2
Mouse monoclonal antibody raised against a full length recombinant SNAPC5. NCBI Entrez Gene ID = SNAPC5...
Mouse monoclonal antibody raised against a partial recombinant CRKRS. NCBI Entrez Gene ID = CRKRS...
Mouse monoclonal antibody raised against a partial recombinant CRKRS. NCBI Entrez Gene ID = CRKRS...
Mouse monoclonal antibody raised against a partial recombinant PRKG1. NCBI Entrez Gene ID = PRKG1...
Biology Products: